Format

Send to

Choose Destination
Stem Cell Res Ther. 2019 Jan 8;10(1):7. doi: 10.1186/s13287-018-1087-7.

Clonal derivation of white and brown adipocyte progenitor cell lines from human pluripotent stem cells.

Author information

1
AgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA.
2
University of California, Berkeley, CA, 94720, USA.
3
AgeX Therapeutics, Inc., 1010 Atlantic Ave, Alameda, CA, 94501, USA. dlarocca@agexinc.com.
4
Johns Hopkins University, Baltimore, MD, 21218, USA.
5
Metabolon Inc., Morrisville, NC, 27560, USA.
6
Zen-Bio, Inc., Research Triangle Park, NC, 27709, USA.
7
SENS Research Foundation, Mountain View, CA, 94041, USA.
8
BioTime, Inc., Alameda, CA, 94501, USA.

Abstract

BACKGROUND:

The role of brown fat in non-shivering thermogenesis and the discovery of brown fat depots in adult humans has made it the subject of intense research interest. A renewable source of brown adipocyte (BA) progenitors would be highly valuable for research and therapy. Directed differentiation of human pluripotent stem (hPS) cells to white or brown adipocytes is limited by lack of cell purity and scalability. Here we describe an alternative approach involving the identification of clonal self-renewing human embryonic progenitor (hEP) cell lines following partial hPS cell differentiation and selection of scalable clones.

METHODS:

We screened a diverse panel of hPS cell-derived clonal hEP cell lines for adipocyte markers following growth in adipocyte differentiation medium. The transcriptome of the human hES-derived clonal embryonic progenitor cell lines E3, C4ELS5.1, NP88, and NP110 representing three class of definitive adipocyte progenitors were compared to the relatively non-adipogenic line E85 and adult-derived BAT and SAT-derived cells using gene expression microarrays, RT-qPCR, metabolic analysis and immunocytochemistry. Differentiation conditions were optimized for maximal UCP1 expression.

RESULTS:

Many of the differentiated hEP cell lines expressed the adipocyte marker, FAPB4, but only a small subset expressed definitive adipocyte markers including brown adipocyte marker, UCP1. Class I cells (i.e., E3) expressed CITED1, ADIPOQ, and C19orf80 but little to no UCP1. Class II (i.e., C4ELS5.1) expressed CITED1 and UCP1 but little ADIPOQ and LIPASIN. Class III (i.e., NP88, NP110) expressed CITED1, ADIPOQ, C19orf80, and UCP1 in a similar manner as fetal BAT-derived (fBAT) cells. Differentiated NP88 and NP110 lines were closest to fBAT cells morphologically in adiponectin and uncoupling protein expression. But they were more metabolically active than fBAT cells, had higher levels of 3-hydroxybutyrate, and lacked expression of fetal/adult marker, COX7A1. The hEP BA progenitor lines were scalable to 17 passages without loss of differentiation capacity and could be readily rederived.

CONCLUSIONS:

Taken together, these data demonstrate that self-renewing adipocyte progenitor cells can be derived from hES cells and that they are functionally like BAT cells but with unique properties that might be advantageous for basic research and for development of cell-based treatments for metabolic diseases.

Supplemental Content

Full text links

Icon for BioMed Central Icon for PubMed Central
Loading ...
Support Center